CymitQuimica logo

CAS 745013-59-6

:

Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
  • Tremelimumab
    Targetmol
    + Info

    Tremelimumab

    CAS:

    Tremelimumab, a CTLA-4 blocker, is used with Durvalumab to treat solid tumors like liver and lung cancer.

    Purity:SDS-PAGE:95.4%;SEC-HPLC:98.7%
    Color and Shape:Liquid
    Molecular weight:146.3 kDa

    Ref: TM-T77466

    1mg
    153.00€
    5mg
    449.00€
    10mg
    655.00€
    25mg
    1,026.00€
    50mg
    1,388.00€
    100mg
    1,872.00€
  • Tremelimumab
    Biosynth
    + Info

    Tremelimumab

    CAS:
    Anti-Human CTLA4 Monoclonal Antibody

    Ref: 3D-CLA1189

    ne
    To inquire